Drug Rash with Eosinophilia and Systemic Symptoms Syndrome: Case Report and Literature Review

1 Tas S, Simonart T. Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Clin Belg. 1999;54(4):197-200. PMid:10544509 Search in Google Scholar

2 Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): Incidence, pathogenesis and management. Expert Opin Drug Saf. 2017;16(2):139-47. https://doi.org/10.1080/14740338.2017.1270940 PMid:27936971 Search in Google Scholar

3 Gaffey CM, Chun B, Harvey JC, Manz HJ. Phenytoin-induced systemic granulomatous vasculitis. Arch Pathol Lab Med. 1986;110(2):131-5. PMid:3753844 Search in Google Scholar

4 Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071-80. https://doi.org/10.1111/bjd.12501 PMid:23855313 Search in Google Scholar

5 Mizukawa Y, Hirahara K, Kano Y, Shiohara T. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J Am Acad Dermatol. 2019;80(3):670-8.e2. https://doi.org/10.1016/j.jaad.2018.08.052 PMid:30240780 Search in Google Scholar

6 Shalom R, Rimbroth S, Rozenman D, Markel A. Allopurinol-induced recurrent DRESS syndrome: Pathophysiology and treatment. Ren Fail. 2008;30(3):327-9. https://doi.org/10.1080/08860220701861045 PMid:18350453 Search in Google Scholar

7 Hama N, Abe R, Gibson A, Phillips EJ. Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): Clinical features and pathogenesis. J Allergy Clin Immunol Pract. 2022;10(5):1155-67.e5. https://doi.org/10.1016/j.jaip.2022.02.004 PMid:35176506 Search in Google Scholar

8 Ben m’rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, et al. Drug-induced hypersensitivity syndrome: Clinical and biologic disease patterns in 24 patients. Medicine (Baltimore). 2009;88(3):131-40. https://doi.org/10.1097/MD.0b013e3181a4d1a1 PMid:19440116 Search in Google Scholar

9 Kleier RS, Breneman DL, Boiko S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol. 1991;127(9):1361-4. PMid:1832535 Search in Google Scholar

10 Lee HY, Tay LK, Thirumoorthy T, Pang SM. Cutaneous adverse drug reactions in hospitalised patients. Singapore Med J. 2010;51(10):767-74. PMid:21103811 Search in Google Scholar

11 Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): A reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int. 2006;56(1):1-8. https://doi.org/10.2332/allergolint.55.1 PMid:17075280 Search in Google Scholar

12 Hansel K, Bellini V, Bianchi L, Brozzi J, Stingeni L. Drug reaction with eosinophilia and systemic symptoms from ceftriaxone confirmed by positive patch test: An immunohistochemical study. J Allergy Clin Immunol Pract. 2017;5(3):808-10. https://doi.org/10.1016/j.jaip.2016.10.009 PMid:27923648 Search in Google Scholar

13 Shiohara T, Mizukawa Y. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergol Int. 2019;68(3):301-8. https://doi.org/10.1016/j.alit.2019.03.006 PMid:31000444 Search in Google Scholar

14 Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;157(5):934-40. https://doi.org/10.1111/j.1365-2133.2007.08167.x PMid:17854362 Search in Google Scholar

15 Sekiguchi A, Kashiwagi T, Ishida-Yamamoto A, Takahashi H, Hashimoto Y, Kimura H, et al. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation. J Dermatol. 2005;32(4):278-81. https://doi.org/10.1111/j.1346-8138.2005.tb00762.x PMid:15863850 Search in Google Scholar

16 Skowron F, Bensaid B, Balme B, Depaepe L, Kanitakis J, Nosbaum A, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): Clinicopathological study of 45 cases. J Eur Acad Dermatol Venereol. 2015;29(11):2199-205. https://doi.org/10.1111/jdv.13212 PMid:26354734 Search in Google Scholar

17 Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol. 2001;137(3):301-4. PMid:11255328 Search in Google Scholar

18 Shiohara T, Ushigome Y, Kano Y, Takahashi R. Crucial role of viral reactivation in the development of severe drug eruptions: A comprehensive review. Clin Rev Allergy Immunol. 2015;49:192-202. https://doi.org/10.1007/s12016-014-8421-3 PMid:24736996 Search in Google Scholar

19 Niu J, Jia Q, Ni Q, Yang Y, Chen G, Yang X, et al. Association of CD8(+) T lymphocyte repertoire spreading with the severity of DRESS syndrome. Sci Rep. 2015;6(1):9913. https://doi.org/10.1038/srep09913 PMid:25905582 Search in Google Scholar

20 Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: A literature review. Am J Med. 2011;124(7):588-97. https://doi.org/10.1016/j.amjmed.2011.01.017 PMid:21592453 Search in Google Scholar

21 Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol. 2013;68(5):693. e1-14; quiz 706-8. https://doi.org/10.1016/j.jaad.2013.01.033 PMid:23602182 Search in Google Scholar

22 Markel A. Allopurinol-induced DRESS syndrome. IMAJ-RAMAT GAN. 2005;7(10):656-60. PMid:16259349 Search in Google Scholar

23 Yaylacı S, Demir MV, Temiz T, Tamer A, Uslan MI. Allopurinol-induced DRESS syndrome. Indian J Pharmacol. 2012;44(3):412. https://doi.org/10.4103/0253-7613.96351 PMid:22701258 Search in Google Scholar

24 Thankachen J, Agarwal V. Challenges in diagnosis, management, and treatment of allopurinol-induced DRESS syndrome: Case report and literature review. Am J Ther. 2015;22(3):e77-83. https://doi.org/10.1097/MJT.0000000000000037 PMid:24451301 Search in Google Scholar

25 Picard D, Janela B, Descamps V, D’Incan M, Courville P, Jacquot S, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): A multiorgan antiviral T cell response. Sci Transl Med. 2010;2(46):46ra62. https://doi.org/10.1126/scitranslmed.3001116 PMid:20739682 Search in Google Scholar

26 Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N. Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis. BMC Med Genet. 2011;12:118. https://doi.org/10.1186/1471-2350-12-118 PMid:21906289 Search in Google Scholar

27 Mardivirin L, Valeyrie-Allanore L, Branlant-Redon E, Beneton N, Jidar K, Barbaud A, et al. Amoxicillin-induced flare in patients with DRESS (drug reaction with eosinophilia and systemic symptoms): Report of seven cases and demonstration of a direct effect of amoxicillin on human herpesvirus 6 replication in vitro. Eur J Dermatol. 2010;20(1):68-73. https://doi.org/10.1684/ejd.2010.0821 PMid:19822481 Search in Google Scholar